Codeine Market - Size, Share,
Opportunity Analysis, 2018 – 2026
Outlook,
and
Codeine is a drug of class known as opioids, widely used in the treatment and management of
mild to moderate pain, severe pain, dry irritating cough, diarrhea, and cold and flu (when
combined with antihistamines and decongestants). Opioids interact with opioid receptors in the
brain and induce effects such as pain relief, relaxation, pleasure, and contentment. Codeine is
usually swallowed and comes in different forms, including tablets, capsules, and
solutions/syrups.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/2297
Codeine Market Drivers
Codeine is widely used in the treatment and management of pain and cough. High prevalence
of pain due to increasing ageing population in key regions such as North America, and Asia-
Pacific is expected to significantly increase demand for codeine formulation and drive global
codeine market growth over the forecast period.
For instance, according to the data published by National Health Interview Survey (NHIS) in
2016, it was estimated that around 20.4% (50.0 million) of the adults in the U.S. are suffering
from chronic pain and around 8.0% of adults in the U.S. (19.6 million) had high impact chronic
pain.
According to a study published by the National Centre for Biotechnology Information (NCBI) in
2015, around 19.6% of the individuals aged between 20 to 60 years were suffering from low
back pain worldwide.
Codeine Market Regional Analysis
North America codeine market is expected to hold a dominant position in the global codeine
market and to account for largest market share over the forecast period, owing to high presence
of key players in the region and approval and launch of novel products by them in the region.